Monkeypox Virus Dissemination in Case of Intranasal Infection of Mice

By the experiments of in vivo intranasal infection of 8-10-days-old outbread ICR mice with Monkeypox virus (MPV) in a dose equal 3.83 lg FFU/specimen, investigated was dynamics of the virus accumulation within various organs, blood cells, and blood serum. In 2 days after infection MPV was detected in blood cells, nasal cavity, lungs, spleen, and duodenum, and in 5 days after - in brain, trachea, liver, kidneys, and blood serum. It was established that 7 days after infection the highest level of MPV production was in the lungs, nasal cavity, and brain, where virus titers in 5 % homogenates were (5.7±0.1), (5.5±0.1), and (5.3±0.3) lg FFU/ml, respectively. In the blood cells virus was traced in 2, 5, and 7 days after challenge, while in blood serum - in 5 and 7 days. MPV blood transfer to the secondary target organs (liver, spleen, duodenum, kidneys, et al. ) was operational, probably, due to the virus proliferation in blood corpuscles. The data obtained and the worked out scheme of MPV dissemination in an organism can be used for the selection and construction of therapeutic anti-pox virus preparations with precise targeted drug delivery.

вирус оспы обезьян, аутбредные мыши, интраназальное инфицирование, динамика накопления, диссеминация, monkeypox virus, outbread mice, intranasal infection, dynamics of accumulation, dissemination

1. Zaks L. [Statistical Estimation]. M.: Statistika; 1976. 598 p.

2. [Guidelines on laboratory animal care and use]. Washington, D.C.: National Academy Press; 1996. 138 p.

3. Sergeev Al.A., Bulychev L.E., P’yankov O.V., Sergeev Ar.A., Bodnev S.A., Kabanov A.S., Tumanov Yu.V., Yurganova I.A., Shishkina L.N., Agafonov A.P., Sergeev A.N. [Sensitivity of different animal species to monkeypox virus]. Probl. Osobo Opasn. Infek. 2012; 1(111):88–92.

4. Sergeev Al.A., Kabanov A.S., Bulychev L.E., P’yankov O.V., Sergeev Ar.A., Taranov O.S., Bodnev S.A., Tumanov Yu.V., Shishkina L.N., Agafonov A.P., Sergeev A.N. [Mice as animal model for evaluation of therapeutic efficacy of preparations against Monkeypox]. Probl. Osobo Opasn. Infek. 2013; 2:60–5.

5. Americo J.L., Moss B., Earl P.L. Identification of wild-derived Inbred mouse strains highly susceptible to monkeypox virus Infection for use as small animal models. J. Virol. 2010; 84(16):8172–80.

6. Biagini P., Thèves C., Balaresque P., Géraut A., Cannet C., Keyser C., Nikolaeva D., Gérard P., Duchesne S., Orlando L., Willerslev E., Alekseev A.N., de Micco P., Ludes B., Crubézy E. Variola virus in a 300-year-old Siberian mummy. N. Engl. J. Med. 2012; 367:2057–9.

7. Cann J.A., Jahrling P.B., Hensley L.E., Wahl-Jensen V. Comparative pathology of smallpox and monkeypox in man and macaques. J. Comp. Path. 2013; 148:6–21.

8. Leparc-Goffart I., Poirier B., Garin D., Tissier M.-H., Fuchs F., Crance J.-M. Standartization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation. J. Clin. Virol. 2005; 32:47–52.

9. Osorio J.E., Iams K.P., Meteyer C.U., Rocke T.E. Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging. PLoS ONE. 2009; 4(8):e6592.

10. Reed K.D., Melski J.W., Graham M.B., Regnery R.L., Sotir M.J., Wegner M.V., Kazmierczak J.J., Stratman E.J., Yu Li, Fairley J.A., Swain G.R., Olson V.A., Sargent E.K., Kehl S.C., Frace M.A., Kline R., Foldy S.L., Davis J.P., Damon I.K. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 2004; 350:342–50.

11. Schultz D.A., Sagartz J.E., Huso D.L., Mark R., Buller L. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. J. Virol. 2009; 383(1):86–92.

12. Zaucha G., Jahrling P., Geisbert T., Swearengen J., Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 2001; 81:1581–600.